CLINICAL TESTING
PATIENT
PHARMA SERVICES
ABOUT US
Every patient’s tumor is different and changes all the time
Response rates of patients to even the
most targeted drugs
is 30% at best
Traditional models of discovery are poorly predictive of patient response
